Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Will Lab-Developed Test Makers Be Subject To Device Tax? It Depends, Shuren Suggests At Hearing

This article was originally published in The Gray Sheet

Executive Summary

Lawmakers at a Sept. 9 House Energy and Commerce Subcommittee raised questions on whether FDA’s plans to regulate lab developed tests will also make labs subject to the device excise tax.

Advertisement

Related Content

Lawmakers Seek Input On Dx Regs, With Lab-Developed Tests In Focus
Lawmakers Seek Input On Dx Regs, With Lab-Developed Tests In Focus
FDA Releases LDT Regulatory Framework, Notification Draft Guidances
FDA Urged To Moderate Evidence Requirements In LDT Framework
Lab Groups’ LDT Comments Will Highlight Barriers To Test Accessibility
FDA Plan To Regulate LDTs Includes Long Phase-In, Unmet-Need Exceptions
Clinical Labs Join Medical Device User Fee Negotiations

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT033295

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel